methadone has been researched along with 2019 Novel Coronavirus Disease in 100 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although hepatitis C virus (HCV) prevails in patients receiving methadone maintenance treatment (MMT), most do not receive anti-HCV therapy." | 8.12 | Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic. ( Chan, HW; Chang, TT; Changchien, TC; Chen, CC; Chen, TH; Huang, CK; Lin, PC; Sie, YT; Tai, CM; Tsai, CT; Tseng, CH; Wang, DW; Yen, YC; Yu, ML, 2022) |
| "To assess whether the methadone take-home policy change was associated with drug overdose deaths among different racial, ethnic, and sex groups." | 4.31 | Racial, Ethnic, and Sex Differences in Methadone-Involved Overdose Deaths Before and After the US Federal Policy Change Expanding Take-home Methadone Doses. ( Bao, Y; Harris, RA; Long, JA; Mandell, DS, 2023) |
| "Although hepatitis C virus (HCV) prevails in patients receiving methadone maintenance treatment (MMT), most do not receive anti-HCV therapy." | 4.12 | Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic. ( Chan, HW; Chang, TT; Changchien, TC; Chen, CC; Chen, TH; Huang, CK; Lin, PC; Sie, YT; Tai, CM; Tsai, CT; Tseng, CH; Wang, DW; Yen, YC; Yu, ML, 2022) |
| "Regulatory changes made during the COVID-19 public health emergency (PHE) that relaxed criteria for take-home dosing (THD) of methadone offer an opportunity to improve quality of care with a lifesaving treatment." | 3.30 | Clinics Optimizing MEthadone Take-homes for opioid use disorder (COMET): Protocol for a stepped-wedge randomized trial to facilitate clinic level changes. ( Bao, Y; Choi, S; Cleland, CM; D'Aunno, T; Hong, S; Knopf, E; Neighbors, CJ; O'Grady, MA; Ramsey, KS, 2023) |
| " Less than 1% of pillbox alerts were for medication being consumed outside the dosing window and we observed no evidence of actual or attempted methadone diversion." | 3.01 | Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic. ( Brooner, RK; Dunn, KE; Stoller, KB, 2021) |
| " The restrictions on methadone availability including take-home dosing were loosened during the COVID-19 pandemic although there have been concerns about the high street value of diverted methadone." | 1.91 | Examination of methadone involved overdoses during the COVID-19 pandemic. ( Kaufman, DE; Kennalley, AL; McCall, KL; Piper, BJ, 2023) |
| " Many settings across North America relaxed restrictions for take-home dosing during the COVID-19 pandemic and have reported consistent or improved patient outcomes." | 1.91 | Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014-20. ( Dale, L; Guerra-Alejos, BC; Kurz, M; Min, JE; Nosyk, B; Piske, M, 2023) |
| "Policymakers should consider patients' perspectives to foster a more patient-centered approach to methadone dosing that is safe, flexible, and accommodating to a diverse array of patients' needs." | 1.91 | Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore. ( Abidogun, TM; Belcher, AM; Cole, TO; Greenblatt, AD; Kleinman, M; Magidson, JF; Massey, E; Seitz-Brown, CJ, 2023) |
| " The community-driven research (CDR) online survey collected information on how patient take-home methadone dosing and in-person drug testing, counseling, and clinic visit frequency changed prior to COVID-19 (before March 2020) to during COVID-19 (June and July 2020)." | 1.91 | Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey. ( Brothers, S; Coulter, A; Palayew, A; Simon, C; Strichartz, K; Vincent, L; Voyles, N, 2023) |
| " However, a growing body of evidence and clinical experience shows that some patients may benefit from twice-daily ("split") dosing to produce more stable symptoms and minimize side effects, independent of serum peak-to-trough levels." | 1.91 | Individualizing methadone treatment with split dosing: An underutilized tool. ( Braun, HM; Potee, RA, 2023) |
| " In individual cases, patients' substance use was identified as key factor necessitating a reintroduction of supervised dosing and drug screening." | 1.91 | Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences. ( Bech, AB; Clausen, T; McDonald, R, 2023) |
| "This study demonstrates variability in methadone dosing regimens among shelter residents." | 1.91 | Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown. ( Bhoora, U; Janse van Rensburg, M; Siemens, JA, 2023) |
| "Methadone, an OUD treatment, has been shown to be effective in reducing the risk of overdose and improving overall health and quality of life." | 1.91 | Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic. ( Fanelli, JL; Furst, JA; Jarvis, MA; Kennalley, AL; McCall, KL; Mynarski, NJ; Nichols, SD; Piper, BJ, 2023) |
| "The proportion of opioid overdose deaths increased by 36% post-COVID emergence (95% CI: 14%, 59%)." | 1.72 | Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas. ( Fairman, BJ; Rezaeiahari, M, 2022) |
| "Video observation of methadone take-home dosing implemented during the COVID-19 pandemic was feasible." | 1.72 | Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic. ( Blalock, KL; Darnton, J; Grekin, P; Hallgren, KA; Michaels, A; Saxon, AJ; Soth, S; Tsui, JI; Woolworth, S, 2022) |
| "Opioid withdrawal symptoms were experienced by 54 participants (93%) whilst taking tramadol." | 1.72 | Managing acute opioid withdrawal with tramadol during COVID-19 lockdown in a peri-urban setting. ( Bhoora, U; Gloeck, NR; Scheibe, A, 2022) |
| "2%) of methadone patients indicated that some form of multi-day take home dosing was offered at their clinic, and 45." | 1.72 | Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID. ( Andres, HJ; Arredondo, C; Bentele, KG; Brady, BR; Coles, H; Downer, M; Garcia, RC; Garnett, I; Granillo, B; Lutz, R; Mahoney, A; Meyerson, BE; Russell, DM; Samorano, S, 2022) |
| "Relaxation of federal regulations for methadone take-out dosing during the COVID-19 pandemic is unprecedented." | 1.72 | Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year. ( Bart, G; Hodges, JS; Rosenthal, R; Wastvedt, S, 2022) |
| "Relaxed restrictions on medications for opioid use disorder created opportunities for improved patient-centered care." | 1.72 | "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston. ( Bagley, SM; Gunn, CM; Harris, MTH; Lambert, AM; Maschke, AD; Walley, AY, 2022) |
| "Methadone is a highly effective treatment for opioid use disorder." | 1.72 | Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations. ( Doyon, S; Hart, K; Welsh, C, 2022) |
| " It is important to evaluate the changes in unsupervised OAT dosing after the release of the Ontario COVID-19 OAT Guidance based on patients' and prescribers' reports." | 1.72 | Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients' and prescribers' experiences with changes in unsupervised dosing. ( Barrass, S; Corace, K; Cragg, S; Hutton, B; Konefal, S; Leece, P; Pana, P; Porath, A; Suschinsky, K; Wyman, J, 2022) |
| "Primary outcomes were opioid overdose, interruption in OAT, and OAT discontinuation." | 1.72 | Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation. ( Antoniou, T; Bozinoff, N; Campbell, TJ; Garg, R; Gomes, T; Kitchen, SA; Men, S; Munro, C; Tadrous, M; Werb, D; Wyman, J, 2022) |
| " However, given that changes were small, strategies to improve retention in OAT and ensure equitable access to take-home dosing should continue." | 1.72 | Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis. ( Antoniou, T; Bozinoff, N; Campbell, TJ; Gomes, T; Kitchen, SA; Men, S; Munro, C; Tadrous, M; Werb, D; Wyman, J, 2022) |
| " Semi-structured qualitative interviews (n = 32) explored patient reactions to increased take-home dosing and reduced clinic visits to provide context for quantitative findings." | 1.72 | Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis. ( Cook, R; Foot, C; Hoffman, KA; Korthuis, PT; Levander, XA; McCarty, D; McIlveen, JW; Terashima, JP, 2022) |
| "These results suggest that the Spokane OTP quickly expanded take-home medication dosing in response to the COVID-19 exemption and broadly expanded take-home dosing among established clients." | 1.72 | Changes in methadone take-home dosing before and after COVID-19. ( Amiri, S; Amram, O; Joudrey, PJ; Lutz, R; Thorn, EL, 2022) |
| "Looking forward, to address both opioid use disorder and COVID-19, jails and prisons need to develop capacity to implement mitigation strategies, including universal and rapid COVID-19 testing of staff and incarcerated individuals, and be resourced to provide evidence-based addiction treatment." | 1.62 | COVID-19 and treating incarcerated populations for opioid use disorder. ( Donelan, CJ; Evans, EA; Hayes, E; Potee, RA; Schwartz, L, 2021) |
| "Methadone maintenance treatment (MMT) in the United States, and particularly the clinic system of distribution, is often criticized as punitive, over-regulated, and misaligned to the needs of many patients." | 1.62 | A chance to do it better: Methadone maintenance treatment in the age of Covid-19. ( Frank, D, 2021) |
| "Our study found variation in experiences of take-home dosing by clinic and little diversion of take-home doses." | 1.62 | Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. ( Dasgupta, N; Day, E; Figgatt, MC; Salazar, Z; Vincent, L, 2021) |
| "The opioid use group reported increased substance use and difficulty accessing their preferred substance." | 1.62 | Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder. ( Ball, EL; Becker, SJ; Garner, BR; Hartzler, B; Jacka, BP; Janssen, T; Yap, KR; Yermash, J, 2021) |
| "As the coronavirus disease 2019 (COVID-19) pandemic threatens to worsen the opioid crisis, payers must rapidly deploy policies to ensure care for individuals with opioid use disorder." | 1.62 | Payer strategies to ensure access to care for individuals with opioid use disorder during COVID-19. ( Bachireddy, C; Terplan, M, 2021) |
| " While some clinicians expressed support for the increased flexibility around dosing and use of telemedicine, others expressed concern about increased risk of medication diversion and overdose." | 1.62 | Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study. ( Dopp, AR; Hunter, SB; Ober, AJ; Uscher-Pines, L, 2021) |
| " We also analyzed state-level data on confirmed accidental opioid-involved deaths to assess if relaxation of take-home dosing restrictions and in-person attendance requirements correlated with increased methadone-involved fatal overdose rates." | 1.62 | Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. ( Brothers, S; Heimer, R; Viera, A, 2021) |
| "On March 16, 2020, Ukraine's Ministry of Health issued nonspecific interim guidance to continue enrolling patients in opioid agonist therapies (OAT) and transition existing patients to take-home dosing to reduce community COVID-19 transmission." | 1.62 | Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine. ( Altice, FL; Dvoryak, S; Farnum, SO; Filippovych, M; Fomenko, T; Galvez de Leon, SJ; Islam, ZM; Madden, LM; Meteliuk, A; Pykalo, I, 2021) |
| "Methadone adherence was assessed by UDTs; OUD-related outcomes were assessed by overdose events and ED visits." | 1.62 | The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era. ( Amiri, S; Amram, O; Joudrey, PJ; Lutz, R; Panwala, V; Socias, E, 2021) |
| "Medications for opioid use disorder (MOUD), such as methadone and buprenorphine, are effective strategies for treatment of opioid use disorder (OUD) and reducing overdose risk." | 1.56 | Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. ( Bruneau, J; Cochran, G; Cox, N; Gordon, AJ, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (1.00) | 24.3611 |
| 2020's | 99 (99.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madden, EF | 1 |
| Christian, BT | 1 |
| Lagisetty, PA | 1 |
| Ray, BR | 1 |
| Sulzer, SH | 1 |
| Levander, XA | 3 |
| Pytell, JD | 1 |
| Stoller, KB | 2 |
| Korthuis, PT | 3 |
| Chander, G | 1 |
| Amram, O | 4 |
| Amiri, S | 2 |
| Panwala, V | 2 |
| Lutz, R | 3 |
| Joudrey, PJ | 4 |
| Socias, E | 1 |
| Lister, JJ | 1 |
| Lister, HH | 1 |
| Harris, MTH | 1 |
| Lambert, AM | 1 |
| Maschke, AD | 1 |
| Bagley, SM | 1 |
| Walley, AY | 1 |
| Gunn, CM | 1 |
| Harocopos, A | 1 |
| Nolan, ML | 1 |
| Goldstein, GP | 1 |
| Mantha, S | 1 |
| O'Neill, M | 1 |
| Paone, D | 1 |
| Hoffman, KA | 2 |
| McIlveen, JW | 2 |
| McCarty, D | 3 |
| Terashima, JP | 2 |
| Welsh, C | 1 |
| Doyon, S | 1 |
| Hart, K | 1 |
| Corace, K | 1 |
| Suschinsky, K | 1 |
| Wyman, J | 4 |
| Leece, P | 1 |
| Cragg, S | 1 |
| Konefal, S | 1 |
| Pana, P | 1 |
| Barrass, S | 1 |
| Porath, A | 1 |
| Hutton, B | 1 |
| Gomes, T | 4 |
| Campbell, TJ | 3 |
| Kitchen, SA | 3 |
| Garg, R | 2 |
| Bozinoff, N | 3 |
| Men, S | 3 |
| Tadrous, M | 3 |
| Munro, C | 3 |
| Antoniou, T | 3 |
| Werb, D | 4 |
| Ghanem, N | 1 |
| Dromgoole, D | 1 |
| Hussein, A | 1 |
| Jermyn, RT | 1 |
| Fernández-Tobar, R | 1 |
| Chamorro-Jambrina, C | 1 |
| Pérez-Torres, M | 1 |
| Castiñeiras-Amor, B | 1 |
| Alcántara-Carmona, S | 1 |
| Romera-Ortega, MA | 1 |
| Roberts, L | 1 |
| Suen, LW | 2 |
| Coe, WH | 1 |
| Wyatt, JP | 1 |
| Adams, ZM | 2 |
| Gandhi, M | 1 |
| Batchelor, HM | 1 |
| Castellanos, S | 2 |
| Joshi, N | 2 |
| Satterwhite, S | 2 |
| Pérez-Rodríguez, R | 1 |
| Rodríguez-Guerra, E | 1 |
| Albizu-Garcia, CE | 1 |
| Knight, KR | 3 |
| Jordan, A | 1 |
| Bouck, Z | 1 |
| Scheim, AI | 1 |
| Ling, V | 1 |
| Caudarella, A | 1 |
| Giang, LM | 1 |
| Trang, NT | 1 |
| Diep, NB | 1 |
| Thuy, DTD | 1 |
| Thuy, DT | 1 |
| Hoe, HD | 1 |
| Van, HTH | 1 |
| Truc, TT | 1 |
| Nguyen, HH | 1 |
| Lai, NL | 1 |
| Linh, PTD | 1 |
| Vi, VTT | 1 |
| Reback, CJ | 1 |
| Leibowitz, A | 1 |
| Li, L | 5 |
| Lin, C | 1 |
| Li, M | 1 |
| Shoptaw, S | 1 |
| Khan, T | 1 |
| Ariyawansa, P | 1 |
| Quinn, J | 1 |
| Hayllar, J | 2 |
| Foot, C | 1 |
| Cook, R | 1 |
| Priest, KC | 1 |
| King, CA | 1 |
| Englander, H | 1 |
| Lovejoy, TI | 1 |
| Ba, I | 1 |
| Desclaux, A | 1 |
| Diop, M | 1 |
| Ndiaye, I | 1 |
| Thiam, MH | 1 |
| Tai, CM | 1 |
| Huang, CK | 1 |
| Changchien, TC | 1 |
| Lin, PC | 1 |
| Wang, DW | 1 |
| Chang, TT | 1 |
| Chan, HW | 1 |
| Chen, TH | 1 |
| Tseng, CH | 1 |
| Chen, CC | 1 |
| Tsai, CT | 1 |
| Sie, YT | 1 |
| Yen, YC | 1 |
| Yu, ML | 1 |
| Russell, C | 1 |
| Lange, S | 1 |
| Kouyoumdjian, F | 1 |
| Butler, A | 1 |
| Ali, F | 1 |
| Rezaeiahari, M | 1 |
| Fairman, BJ | 1 |
| Jones, CM | 1 |
| Shoff, C | 1 |
| Hodges, K | 1 |
| Blanco, C | 1 |
| Losby, JL | 1 |
| Ling, SM | 1 |
| Compton, WM | 1 |
| Hallgren, KA | 2 |
| Darnton, J | 1 |
| Soth, S | 2 |
| Blalock, KL | 1 |
| Michaels, A | 2 |
| Grekin, P | 3 |
| Saxon, AJ | 1 |
| Woolworth, S | 3 |
| Tsui, JI | 3 |
| Bhoora, U | 2 |
| Gloeck, NR | 1 |
| Scheibe, A | 1 |
| Aldabergenov, D | 1 |
| Reynolds, L | 1 |
| Scott, J | 1 |
| Kelleher, MJ | 1 |
| Strang, J | 1 |
| Copeland, CS | 1 |
| Kalk, NJ | 1 |
| Meyerson, BE | 1 |
| Bentele, KG | 1 |
| Russell, DM | 1 |
| Brady, BR | 1 |
| Downer, M | 1 |
| Garcia, RC | 1 |
| Garnett, I | 1 |
| Mahoney, A | 1 |
| Samorano, S | 1 |
| Arredondo, C | 1 |
| Andres, HJ | 1 |
| Coles, H | 1 |
| Granillo, B | 1 |
| Bosch-Arís, M | 1 |
| Gasulla, L | 1 |
| de Gispert, T | 1 |
| Segura, L | 1 |
| Colom, J | 1 |
| Livingston, NA | 2 |
| Davenport, M | 1 |
| Head, M | 1 |
| Henke, R | 1 |
| LeBeau, LS | 1 |
| Gibson, TB | 1 |
| Banducci, AN | 2 |
| Sarpong, A | 1 |
| Jayanthi, S | 1 |
| Roth, C | 1 |
| Camacho-Cook, J | 1 |
| Meng, F | 1 |
| Hyde, J | 1 |
| Mulvaney-Day, N | 1 |
| White, M | 1 |
| Chen, DC | 1 |
| Stein, MD | 1 |
| Weisberg, R | 1 |
| Kleinman, RA | 2 |
| Sanches, M | 2 |
| Moallef, S | 2 |
| DeBeck, K | 3 |
| Fairbairn, N | 3 |
| Cui, Z | 2 |
| Brar, R | 3 |
| Wilson, D | 3 |
| Johnson, C | 3 |
| Milloy, MJ | 2 |
| Hayashi, K | 3 |
| Kaufman, DE | 1 |
| Kennalley, AL | 2 |
| McCall, KL | 2 |
| Piper, BJ | 2 |
| Azimi, HA | 1 |
| Keats, KR | 1 |
| Sulejmani, E | 1 |
| Ortiz, K | 1 |
| Waller, J | 1 |
| Wayne, N | 1 |
| Nosyk, B | 1 |
| Kurz, M | 1 |
| Guerra-Alejos, BC | 1 |
| Piske, M | 1 |
| Dale, L | 1 |
| Min, JE | 1 |
| Rosenkrantz, L | 1 |
| DDes, SA | 1 |
| Schuurman, N | 1 |
| Panwala, VJ | 1 |
| Doshi, S | 1 |
| Kingston, H | 1 |
| Tseng, AS | 1 |
| Chohan, BH | 1 |
| Sambai, B | 1 |
| Guthrie, BL | 1 |
| Monroe-Wise, A | 1 |
| Mbogo, LW | 1 |
| Masyuko, S | 1 |
| Tram, KH | 1 |
| Sinkele, W | 1 |
| Macharia, P | 1 |
| Bukusi, D | 1 |
| Herbeck, JT | 1 |
| Farquhar, C | 1 |
| Krawczyk, N | 3 |
| Rivera, BD | 1 |
| Levin, E | 1 |
| Dooling, BCE | 1 |
| Boogaerts, T | 1 |
| Quireyns, M | 1 |
| De Loof, H | 1 |
| Bertels, X | 1 |
| Van Wichelen, N | 1 |
| Pussig, B | 1 |
| Saevels, J | 1 |
| Lahousse, L | 1 |
| Bonmariage, P | 1 |
| Hamelinck, W | 1 |
| Aertgeerts, B | 1 |
| Covaci, A | 1 |
| van Nuijs, ALN | 1 |
| Abidogun, TM | 1 |
| Cole, TO | 1 |
| Massey, E | 1 |
| Kleinman, M | 1 |
| Greenblatt, AD | 2 |
| Seitz-Brown, CJ | 1 |
| Magidson, JF | 2 |
| Belcher, AM | 2 |
| Brothers, S | 2 |
| Palayew, A | 1 |
| Simon, C | 1 |
| Coulter, A | 1 |
| Strichartz, K | 1 |
| Voyles, N | 1 |
| Vincent, L | 2 |
| Luo, J | 2 |
| Bello, D | 1 |
| Pagsuyoin, S | 1 |
| Scott, G | 1 |
| Turner, S | 1 |
| Lowry, N | 1 |
| Hodge, A | 1 |
| Ashraf, W | 1 |
| McClean, K | 1 |
| Kelleher, M | 1 |
| Mitcheson, L | 1 |
| Marsden, J | 1 |
| Darnton, JB | 1 |
| Bhatraju, EP | 1 |
| Beima-Sofie, K | 1 |
| Taylor, EA | 1 |
| Cantor, JH | 1 |
| Bradford, AC | 1 |
| Simon, K | 1 |
| Stein, BD | 1 |
| Joudrey, P | 1 |
| Kowalski, M | 1 |
| Bach, P | 2 |
| Eugenia Socias, M | 1 |
| Choi, JC | 1 |
| Harris, RA | 1 |
| Long, JA | 1 |
| Bao, Y | 2 |
| Mandell, DS | 1 |
| Choi, S | 1 |
| O'Grady, MA | 1 |
| Cleland, CM | 1 |
| Knopf, E | 1 |
| Hong, S | 1 |
| D'Aunno, T | 1 |
| Ramsey, KS | 1 |
| Neighbors, CJ | 1 |
| Conway, A | 1 |
| Marshall, AD | 1 |
| Crawford, S | 1 |
| Grebely, J | 1 |
| Treloar, C | 1 |
| Braun, HM | 1 |
| Potee, RA | 2 |
| Lehmann, K | 1 |
| Kuhn, S | 1 |
| Schulte, B | 1 |
| Verthein, U | 1 |
| Perino, J | 1 |
| Demourgues, M | 1 |
| Ramaroson, H | 1 |
| Bezin, J | 1 |
| Micallef, J | 1 |
| Miremont-Salamé, G | 1 |
| Frauger, E | 1 |
| Gilleron, V | 1 |
| Ong, N | 1 |
| Daveluy, A | 1 |
| McDonald, R | 1 |
| Bech, AB | 1 |
| Clausen, T | 1 |
| Kawasaki, SS | 1 |
| Zimmerman, R | 1 |
| Shen, C | 1 |
| Zgierska, AE | 1 |
| Carvalho, RM | 1 |
| de Magalhães-Barbosa, MC | 1 |
| Bianchi, LM | 1 |
| Rodrigues-Santos, G | 1 |
| da Cunha, AJLA | 1 |
| Bastos, FI | 1 |
| Prata-Barbosa, A | 1 |
| Mitchell, SG | 1 |
| Jester, J | 1 |
| Gryczynski, J | 1 |
| Whitter, M | 1 |
| Fuller, D | 1 |
| Halsted, C | 1 |
| Schwartz, RP | 1 |
| Siemens, JA | 1 |
| Janse van Rensburg, M | 1 |
| Fanelli, JL | 1 |
| Furst, JA | 1 |
| Mynarski, NJ | 1 |
| Jarvis, MA | 1 |
| Nichols, SD | 1 |
| Halim, AA | 1 |
| Alsayed, B | 1 |
| Embarak, S | 1 |
| Yaseen, T | 1 |
| Dabbous, S | 1 |
| Fontaine, O | 1 |
| Dueluzeau, R | 1 |
| Raibaud, P | 1 |
| Chabanet, C | 1 |
| Popoff, MR | 1 |
| Badoual, J | 1 |
| Gabilan, JC | 1 |
| Andremont, A | 1 |
| Gómez, L | 1 |
| Andrés, S | 1 |
| Sánchez, J | 1 |
| Alonso, JM | 1 |
| Rey, J | 1 |
| López, F | 1 |
| Jiménez, A | 1 |
| Yan, Z | 1 |
| Zhou, L | 1 |
| Zhao, Y | 3 |
| Wang, J | 8 |
| Huang, L | 3 |
| Hu, K | 1 |
| Liu, H | 4 |
| Wang, H | 4 |
| Guo, Z | 1 |
| Song, Y | 1 |
| Huang, H | 4 |
| Yang, R | 1 |
| Owen, TW | 1 |
| Al-Kaysi, RO | 1 |
| Bardeen, CJ | 1 |
| Cheng, Q | 1 |
| Wu, S | 1 |
| Cheng, T | 1 |
| Zhou, X | 1 |
| Wang, B | 4 |
| Zhang, Q | 6 |
| Wu, X | 2 |
| Yao, Y | 3 |
| Ochiai, T | 1 |
| Ishiguro, H | 2 |
| Nakano, R | 2 |
| Kubota, Y | 2 |
| Hara, M | 1 |
| Sunada, K | 1 |
| Hashimoto, K | 1 |
| Kajioka, J | 1 |
| Fujishima, A | 1 |
| Jiao, J | 3 |
| Gai, QY | 3 |
| Wang, W | 2 |
| Zang, YP | 2 |
| Niu, LL | 2 |
| Fu, YJ | 3 |
| Wang, X | 4 |
| Yao, LP | 1 |
| Qin, QP | 1 |
| Wang, ZY | 1 |
| Liu, J | 5 |
| Aleksic Sabo, V | 1 |
| Knezevic, P | 1 |
| Borges-Argáez, R | 1 |
| Chan-Balan, R | 1 |
| Cetina-Montejo, L | 1 |
| Ayora-Talavera, G | 1 |
| Sansores-Peraza, P | 1 |
| Gómez-Carballo, J | 1 |
| Cáceres-Farfán, M | 1 |
| Jang, J | 1 |
| Akin, D | 1 |
| Bashir, R | 1 |
| Yu, Z | 1 |
| Zhu, J | 2 |
| Jiang, H | 2 |
| He, C | 2 |
| Xiao, Z | 1 |
| Xu, J | 2 |
| Sun, Q | 1 |
| Han, D | 1 |
| Lei, H | 1 |
| Zhao, K | 2 |
| Zhu, L | 1 |
| Li, X | 5 |
| Fu, H | 2 |
| Wilson, BK | 1 |
| Step, DL | 1 |
| Maxwell, CL | 1 |
| Gifford, CA | 1 |
| Richards, CJ | 1 |
| Krehbiel, CR | 1 |
| Warner, JM | 1 |
| Doerr, AJ | 1 |
| Erickson, GE | 1 |
| Guretzky, JA | 1 |
| Rasby, RJ | 1 |
| Watson, AK | 1 |
| Klopfenstein, TJ | 1 |
| Sun, Y | 4 |
| Liu, Z | 3 |
| Pham, TD | 1 |
| Lee, BK | 1 |
| Yang, FC | 1 |
| Wu, KH | 1 |
| Lin, WP | 1 |
| Hu, MK | 1 |
| Lin, L | 3 |
| Shao, J | 1 |
| Sun, M | 1 |
| Xu, G | 1 |
| Zhang, X | 7 |
| Xu, N | 1 |
| Wang, R | 1 |
| Liu, S | 1 |
| He, H | 1 |
| Dong, X | 2 |
| Yang, M | 2 |
| Yang, Q | 1 |
| Duan, S | 1 |
| Yu, Y | 2 |
| Han, J | 2 |
| Zhang, C | 5 |
| Chen, L | 3 |
| Yang, X | 1 |
| Li, W | 4 |
| Wang, T | 2 |
| Campbell, DA | 1 |
| Gao, K | 1 |
| Zager, RA | 1 |
| Johnson, ACM | 1 |
| Guillem, A | 1 |
| Keyser, J | 1 |
| Singh, B | 1 |
| Steubl, D | 1 |
| Schneider, MP | 1 |
| Meiselbach, H | 1 |
| Nadal, J | 1 |
| Schmid, MC | 1 |
| Saritas, T | 1 |
| Krane, V | 1 |
| Sommerer, C | 1 |
| Baid-Agrawal, S | 1 |
| Voelkl, J | 1 |
| Kotsis, F | 1 |
| Köttgen, A | 1 |
| Eckardt, KU | 1 |
| Scherberich, JE | 1 |
| Li, H | 5 |
| Yao, L | 2 |
| Sun, L | 3 |
| Zhu, Z | 2 |
| Naren, N | 1 |
| Zhang, XX | 2 |
| Gentile, GL | 1 |
| Rupert, AS | 1 |
| Carrasco, LI | 1 |
| Garcia, EM | 1 |
| Kumar, NG | 1 |
| Walsh, SW | 1 |
| Jefferson, KK | 1 |
| Guest, RL | 1 |
| Samé Guerra, D | 1 |
| Wissler, M | 1 |
| Grimm, J | 1 |
| Silhavy, TJ | 1 |
| Lee, JH | 2 |
| Yoo, JS | 1 |
| Kim, Y | 1 |
| Kim, JS | 2 |
| Lee, EJ | 1 |
| Roe, JH | 1 |
| Delorme, M | 1 |
| Bouchard, PA | 1 |
| Simon, M | 1 |
| Simard, S | 1 |
| Lellouche, F | 1 |
| D'Urzo, KA | 1 |
| Mok, F | 1 |
| D'Urzo, AD | 1 |
| Koneru, B | 1 |
| Lopez, G | 1 |
| Farooqi, A | 1 |
| Conkrite, KL | 1 |
| Nguyen, TH | 1 |
| Macha, SJ | 1 |
| Modi, A | 1 |
| Rokita, JL | 1 |
| Urias, E | 1 |
| Hindle, A | 1 |
| Davidson, H | 1 |
| Mccoy, K | 1 |
| Nance, J | 1 |
| Yazdani, V | 1 |
| Irwin, MS | 1 |
| Yang, S | 1 |
| Wheeler, DA | 1 |
| Maris, JM | 1 |
| Diskin, SJ | 1 |
| Reynolds, CP | 1 |
| Abhilash, L | 1 |
| Kalliyil, A | 1 |
| Sheeba, V | 1 |
| Hartley, AM | 2 |
| Meunier, B | 2 |
| Pinotsis, N | 1 |
| Maréchal, A | 2 |
| Xu, JY | 1 |
| Genko, N | 1 |
| Haraux, F | 1 |
| Rich, PR | 1 |
| Kamalanathan, M | 1 |
| Doyle, SM | 1 |
| Xu, C | 1 |
| Achberger, AM | 1 |
| Wade, TL | 1 |
| Schwehr, K | 1 |
| Santschi, PH | 1 |
| Sylvan, JB | 1 |
| Quigg, A | 1 |
| Leong, W | 1 |
| Xu, W | 2 |
| Gao, S | 1 |
| Zhai, X | 1 |
| Wang, C | 2 |
| Gilson, E | 1 |
| Ye, J | 1 |
| Lu, Y | 2 |
| Yan, R | 1 |
| Zhang, Y | 8 |
| Hu, Z | 1 |
| You, Q | 1 |
| Cai, Q | 1 |
| Yang, D | 1 |
| Gu, S | 1 |
| Dai, H | 1 |
| Zhao, X | 2 |
| Gui, C | 1 |
| Gui, J | 1 |
| Wu, PK | 1 |
| Hong, SK | 1 |
| Starenki, D | 1 |
| Oshima, K | 1 |
| Shao, H | 1 |
| Gestwicki, JE | 1 |
| Tsai, S | 1 |
| Park, JI | 1 |
| Wang, Y | 8 |
| Zhao, R | 1 |
| Gu, Z | 1 |
| Dong, C | 2 |
| Guo, G | 1 |
| Barrett, HE | 1 |
| Meester, EJ | 1 |
| van Gaalen, K | 1 |
| van der Heiden, K | 1 |
| Krenning, BJ | 1 |
| Beekman, FJ | 1 |
| de Blois, E | 1 |
| de Swart, J | 1 |
| Verhagen, HJ | 1 |
| Maina, T | 1 |
| Nock, BA | 1 |
| Norenberg, JP | 1 |
| de Jong, M | 1 |
| Gijsen, FJH | 1 |
| Bernsen, MR | 1 |
| Martínez-Milla, J | 1 |
| Galán-Arriola, C | 1 |
| Carnero, M | 1 |
| Cobiella, J | 1 |
| Pérez-Camargo, D | 1 |
| Bautista-Hernández, V | 1 |
| Rigol, M | 1 |
| Solanes, N | 1 |
| Villena-Gutierrez, R | 1 |
| Lobo, M | 1 |
| Mateo, J | 1 |
| Vilchez-Tschischke, JP | 1 |
| Salinas, B | 1 |
| Cussó, L | 1 |
| López, GJ | 1 |
| Fuster, V | 1 |
| Desco, M | 1 |
| Sanchez-González, J | 1 |
| Ibanez, B | 1 |
| van den Berg, P | 1 |
| Schweitzer, DH | 1 |
| van Haard, PMM | 1 |
| Geusens, PP | 1 |
| van den Bergh, JP | 1 |
| Zhu, X | 1 |
| Huang, X | 2 |
| Xu, H | 3 |
| Yang, G | 2 |
| Lin, Z | 1 |
| Salem, HF | 1 |
| Nafady, MM | 1 |
| Kharshoum, RM | 1 |
| Abd El-Ghafar, OA | 1 |
| Farouk, HO | 1 |
| Domiciano, D | 1 |
| Nery, FC | 1 |
| de Carvalho, PA | 1 |
| Prudente, DO | 1 |
| de Souza, LB | 1 |
| Chalfun-Júnior, A | 1 |
| Paiva, R | 1 |
| Marchiori, PER | 1 |
| Lu, M | 2 |
| An, Z | 1 |
| Jiang, J | 2 |
| Li, J | 7 |
| Du, S | 1 |
| Zhou, H | 1 |
| Cui, J | 1 |
| Wu, W | 2 |
| Liu, Y | 8 |
| Song, J | 1 |
| Lian, Q | 1 |
| Uddin Ahmad, Z | 1 |
| Gang, DD | 1 |
| Konggidinata, MI | 1 |
| Gallo, AA | 1 |
| Zappi, ME | 1 |
| Yang, TWW | 1 |
| Johari, Y | 1 |
| Burton, PR | 1 |
| Earnest, A | 1 |
| Shaw, K | 1 |
| Hare, JL | 1 |
| Brown, WA | 1 |
| Kim, GA | 1 |
| Han, S | 1 |
| Choi, GH | 1 |
| Choi, J | 1 |
| Lim, YS | 1 |
| Gallo, A | 1 |
| Cancelli, C | 1 |
| Ceron, E | 1 |
| Covino, M | 1 |
| Capoluongo, E | 1 |
| Pocino, K | 1 |
| Ianiro, G | 1 |
| Cammarota, G | 1 |
| Gasbarrini, A | 1 |
| Montalto, M | 1 |
| Somasundar, Y | 1 |
| Lu, IC | 1 |
| Mills, MR | 1 |
| Qian, LY | 1 |
| Olivares, X | 1 |
| Ryabov, AD | 1 |
| Collins, TJ | 1 |
| Zhao, L | 1 |
| Doddipatla, S | 1 |
| Thomas, AM | 1 |
| Nikolayev, AA | 1 |
| Galimova, GR | 1 |
| Azyazov, VN | 1 |
| Mebel, AM | 1 |
| Kaiser, RI | 1 |
| Guo, S | 1 |
| Yang, P | 1 |
| Yu, X | 2 |
| Wu, Y | 2 |
| Zhang, H | 2 |
| Yu, B | 2 |
| Han, B | 1 |
| George, MW | 1 |
| Moor, MB | 1 |
| Bonny, O | 1 |
| Langenberg, E | 1 |
| Paik, H | 1 |
| Smith, EH | 1 |
| Nair, HP | 1 |
| Hanke, I | 1 |
| Ganschow, S | 1 |
| Catalan, G | 1 |
| Domingo, N | 1 |
| Schlom, DG | 1 |
| Assefa, MK | 1 |
| Wu, G | 2 |
| Hayton, TW | 1 |
| Becker, B | 1 |
| Enikeev, D | 1 |
| Netsch, C | 1 |
| Gross, AJ | 1 |
| Laukhtina, E | 1 |
| Glybochko, P | 1 |
| Rapoport, L | 1 |
| Herrmann, TRW | 1 |
| Taratkin, M | 1 |
| Dai, W | 1 |
| Shi, J | 2 |
| Carreno, J | 1 |
| Kloner, RA | 1 |
| Pickersgill, NA | 1 |
| Vetter, JM | 1 |
| Kim, EH | 1 |
| Cope, SJ | 1 |
| Du, K | 1 |
| Venkatesh, R | 1 |
| Giardina, JD | 1 |
| Saad, NES | 1 |
| Bhayani, SB | 1 |
| Figenshau, RS | 1 |
| Eriksson, J | 1 |
| Landfeldt, E | 1 |
| Ireland, S | 1 |
| Jackson, C | 1 |
| Wyatt, E | 1 |
| Gaudig, M | 1 |
| Stancill, JS | 1 |
| Happ, JT | 1 |
| Broniowska, KA | 1 |
| Hogg, N | 1 |
| Corbett, JA | 1 |
| Tang, LF | 1 |
| Bi, YL | 1 |
| Fan, Y | 2 |
| Sun, YB | 1 |
| Wang, AL | 1 |
| Xiao, BH | 1 |
| Wang, LF | 1 |
| Qiu, SW | 1 |
| Guo, SW | 1 |
| Wáng, YXJ | 1 |
| Sun, J | 2 |
| Chu, S | 1 |
| Pan, Q | 1 |
| Li, D | 2 |
| Zheng, S | 2 |
| Ma, L | 1 |
| Wang, L | 4 |
| Hu, T | 1 |
| Wang, F | 1 |
| Han, Z | 1 |
| Yin, Z | 1 |
| Ge, X | 1 |
| Xie, K | 1 |
| Lei, P | 1 |
| Dias-Santagata, D | 1 |
| Lennerz, JK | 1 |
| Sadow, PM | 1 |
| Frazier, RP | 1 |
| Govinda Raju, S | 1 |
| Henry, D | 1 |
| Chung, T | 1 |
| Kherani, J | 1 |
| Rothenberg, SM | 1 |
| Wirth, LJ | 1 |
| Marti, CN | 1 |
| Choi, NG | 1 |
| Bae, SJ | 1 |
| Ni, L | 1 |
| Luo, X | 1 |
| Dai, T | 1 |
| Yang, Y | 5 |
| Lee, R | 1 |
| Fleischer, AS | 1 |
| Wemhoff, AP | 1 |
| Ford, CR | 1 |
| Kleppinger, EL | 1 |
| Helms, K | 1 |
| Bush, AA | 1 |
| Luna-Abanto, J | 1 |
| García Ruiz, L | 1 |
| Laura Martinez, J | 1 |
| Álvarez Larraondo, M | 1 |
| Villoslada Terrones, V | 1 |
| Dukic, L | 1 |
| Maric, N | 1 |
| Simundic, AM | 1 |
| Chogtu, B | 1 |
| Ommurugan, B | 1 |
| Thomson, SR | 1 |
| Kalthur, SG | 1 |
| Benidir, M | 1 |
| El Massoudi, S | 1 |
| El Ghadraoui, L | 1 |
| Lazraq, A | 1 |
| Benjelloun, M | 1 |
| Errachidi, F | 1 |
| Cassar, M | 1 |
| Law, AD | 1 |
| Chow, ES | 1 |
| Giebultowicz, JM | 1 |
| Kretzschmar, D | 1 |
| Salonurmi, T | 1 |
| Nabil, H | 1 |
| Ronkainen, J | 1 |
| Hyötyläinen, T | 1 |
| Hautajärvi, H | 1 |
| Savolainen, MJ | 1 |
| Tolonen, A | 1 |
| Orešič, M | 1 |
| Känsäkoski, P | 1 |
| Rysä, J | 1 |
| Hakkola, J | 1 |
| Hukkanen, J | 1 |
| Zhu, N | 1 |
| Li, Y | 5 |
| Du, Q | 1 |
| Hao, P | 1 |
| Cao, X | 1 |
| Li, CX | 1 |
| Zhao, S | 1 |
| Luo, XM | 1 |
| Feng, JX | 1 |
| Gonzalez-Cotto, M | 1 |
| Guo, L | 1 |
| Karwan, M | 1 |
| Sen, SK | 1 |
| Barb, J | 1 |
| Collado, CJ | 1 |
| Elloumi, F | 1 |
| Palmieri, EM | 1 |
| Boelte, K | 1 |
| Kolodgie, FD | 1 |
| Finn, AV | 1 |
| Biesecker, LG | 1 |
| McVicar, DW | 1 |
| Qu, F | 1 |
| Deng, Z | 1 |
| Xie, Y | 2 |
| Tang, J | 3 |
| Chen, Z | 2 |
| Luo, W | 1 |
| Xiong, D | 1 |
| Zhao, D | 1 |
| Fang, J | 1 |
| Zhou, Z | 1 |
| Niu, PP | 1 |
| Song, B | 1 |
| Xu, YM | 1 |
| Zhang, Z | 2 |
| Qiu, N | 1 |
| Yin, J | 1 |
| Zhang, J | 4 |
| Guo, W | 1 |
| Liu, M | 2 |
| Liu, T | 2 |
| Chen, D | 6 |
| Luo, K | 1 |
| He, Z | 2 |
| Zheng, G | 1 |
| Xu, F | 1 |
| Sun, W | 1 |
| Yin, F | 1 |
| van Hest, JCM | 1 |
| Du, L | 2 |
| Shi, X | 1 |
| Kang, S | 1 |
| Duan, W | 1 |
| Zhang, S | 2 |
| Feng, J | 2 |
| Qi, N | 1 |
| Shen, G | 1 |
| Ren, H | 1 |
| Shang, Q | 1 |
| Zhao, W | 2 |
| Yang, Z | 2 |
| Jiang, X | 2 |
| Alame, M | 1 |
| Cornillot, E | 1 |
| Cacheux, V | 1 |
| Tosato, G | 1 |
| Four, M | 1 |
| De Oliveira, L | 1 |
| Gofflot, S | 1 |
| Delvenne, P | 1 |
| Turtoi, E | 1 |
| Cabello-Aguilar, S | 1 |
| Nishiyama, M | 1 |
| Turtoi, A | 1 |
| Costes-Martineau, V | 1 |
| Colinge, J | 1 |
| Guo, Q | 1 |
| Quan, M | 1 |
| Dong, J | 1 |
| Bai, J | 1 |
| Han, R | 1 |
| Cai, Y | 1 |
| Lv, YQ | 1 |
| Chen, Q | 1 |
| Lyu, HD | 1 |
| Deng, L | 1 |
| Zhou, D | 1 |
| Xiao, X | 1 |
| De Langhe, S | 1 |
| Billadeau, DD | 1 |
| Lou, Z | 1 |
| Zhang, JS | 1 |
| Xue, Z | 1 |
| Shen, XD | 1 |
| Gao, F | 1 |
| Busuttil, RW | 1 |
| Kupiec-Weglinski, JW | 1 |
| Ji, H | 1 |
| Otano, I | 1 |
| Alvarez, M | 1 |
| Minute, L | 1 |
| Ochoa, MC | 1 |
| Migueliz, I | 1 |
| Molina, C | 1 |
| Azpilikueta, A | 1 |
| de Andrea, CE | 1 |
| Etxeberria, I | 1 |
| Sanmamed, MF | 1 |
| Teijeira, Á | 1 |
| Berraondo, P | 1 |
| Melero, I | 1 |
| Zhong, Z | 1 |
| Xie, X | 1 |
| Yu, Q | 1 |
| Zhou, C | 1 |
| Liu, C | 2 |
| Liu, W | 1 |
| Chen, W | 2 |
| Yin, Y | 2 |
| Li, CW | 1 |
| Hsu, JL | 1 |
| Zhou, Q | 1 |
| Hu, B | 1 |
| Fu, P | 1 |
| Atyah, M | 1 |
| Ma, Q | 3 |
| Xu, Y | 1 |
| Dong, Q | 1 |
| Hung, MC | 1 |
| Ren, N | 1 |
| Huang, P | 1 |
| Liao, R | 1 |
| Chen, X | 4 |
| Cao, Q | 1 |
| Yuan, X | 1 |
| Nie, W | 1 |
| Yang, J | 2 |
| Shao, B | 1 |
| Ma, X | 1 |
| Bi, Z | 1 |
| Liang, X | 1 |
| Tie, Y | 1 |
| Mo, F | 1 |
| Xie, D | 1 |
| Wei, Y | 1 |
| Wei, X | 2 |
| Dokla, EME | 1 |
| Fang, CS | 1 |
| Chu, PC | 1 |
| Chang, CS | 1 |
| Abouzid, KAM | 1 |
| Chen, CS | 1 |
| Blaszczyk, R | 1 |
| Brzezinska, J | 1 |
| Dymek, B | 1 |
| Stanczak, PS | 1 |
| Mazurkiewicz, M | 1 |
| Olczak, J | 1 |
| Nowicka, J | 1 |
| Dzwonek, K | 1 |
| Zagozdzon, A | 1 |
| Golab, J | 1 |
| Golebiowski, A | 1 |
| Xin, Z | 1 |
| Himmelbauer, MK | 1 |
| Jones, JH | 1 |
| Enyedy, I | 1 |
| Gilfillan, R | 1 |
| Hesson, T | 1 |
| King, K | 1 |
| Marcotte, DJ | 1 |
| Murugan, P | 1 |
| Santoro, JC | 1 |
| Gonzalez-Lopez de Turiso, F | 1 |
| Pedron, J | 1 |
| Boudot, C | 1 |
| Brossas, JY | 1 |
| Pinault, E | 1 |
| Bourgeade-Delmas, S | 1 |
| Sournia-Saquet, A | 1 |
| Boutet-Robinet, E | 1 |
| Destere, A | 1 |
| Tronnet, A | 1 |
| Bergé, J | 1 |
| Bonduelle, C | 1 |
| Deraeve, C | 1 |
| Pratviel, G | 1 |
| Stigliani, JL | 1 |
| Paris, L | 1 |
| Mazier, D | 1 |
| Corvaisier, S | 1 |
| Since, M | 1 |
| Malzert-Fréon, A | 1 |
| Wyllie, S | 1 |
| Milne, R | 1 |
| Fairlamb, AH | 1 |
| Valentin, A | 1 |
| Courtioux, B | 1 |
| Verhaeghe, P | 1 |
| Fang, X | 1 |
| Gao, M | 1 |
| Gao, H | 1 |
| Bi, W | 1 |
| Tang, H | 1 |
| Cui, Y | 2 |
| Zhang, L | 4 |
| Fan, H | 1 |
| Yu, H | 1 |
| Mathison, CJN | 1 |
| Chianelli, D | 1 |
| Rucker, PV | 1 |
| Nelson, J | 1 |
| Roland, J | 1 |
| Huang, Z | 2 |
| Xie, YF | 1 |
| Epple, R | 1 |
| Bursulaya, B | 1 |
| Lee, C | 1 |
| Gao, MY | 1 |
| Shaffer, J | 1 |
| Briones, S | 1 |
| Sarkisova, Y | 1 |
| Galkin, A | 1 |
| Li, N | 1 |
| Li, C | 2 |
| Hua, S | 1 |
| Kasibhatla, S | 1 |
| Kinyamu-Akunda, J | 1 |
| Kikkawa, R | 1 |
| Molteni, V | 1 |
| Tellew, JE | 1 |
| Jin, X | 1 |
| Pang, B | 1 |
| Liu, Q | 2 |
| Liu, X | 6 |
| Huang, Y | 2 |
| Josephine Fauci, A | 1 |
| Ma, Y | 1 |
| Soo Lee, M | 1 |
| Yuan, W | 1 |
| Gao, R | 1 |
| Qi, H | 1 |
| Zheng, W | 1 |
| Yang, F | 2 |
| Chua, H | 1 |
| Wang, K | 1 |
| Ou, Y | 1 |
| Huang, M | 1 |
| Zhu, Y | 2 |
| Yu, J | 1 |
| Tian, J | 1 |
| Zhao, M | 2 |
| Hu, J | 1 |
| Yao, C | 1 |
| Zhang, B | 1 |
| Usawachintachit, M | 1 |
| Tzou, DT | 1 |
| Washington, SL | 1 |
| Hu, W | 1 |
| Chi, T | 1 |
| Sorensen, MD | 1 |
| Bailey, MR | 1 |
| Hsi, RS | 1 |
| Cunitz, BW | 1 |
| Simon, J | 1 |
| Wang, YN | 1 |
| Dunmire, BL | 1 |
| Paun, M | 1 |
| Starr, F | 1 |
| Lu, W | 1 |
| Evan, AP | 1 |
| Harper, JD | 1 |
| Han, G | 1 |
| Rodrigues, AE | 1 |
| Fouladvand, F | 1 |
| Falahi, E | 1 |
| Asbaghi, O | 1 |
| Abbasnezhad, A | 1 |
| Anigboro, AA | 1 |
| Avwioroko, OJ | 1 |
| Cholu, CO | 1 |
| Sonei, A | 1 |
| Fazelipour, S | 1 |
| Kanaani, L | 1 |
| Jahromy, MH | 1 |
| Jo, K | 1 |
| Hong, KB | 1 |
| Suh, HJ | 1 |
| Park, JH | 1 |
| Shin, E | 1 |
| Park, E | 1 |
| Kouakou-Kouamé, CA | 1 |
| N'guessan, FK | 1 |
| Montet, D | 1 |
| Djè, MK | 1 |
| Kim, GD | 1 |
| González-Fernández, D | 1 |
| Pons, EDC | 1 |
| Rueda, D | 1 |
| Sinisterra, OT | 1 |
| Murillo, E | 1 |
| Scott, ME | 1 |
| Koski, KG | 1 |
| Shete, PB | 1 |
| Gonzales, R | 1 |
| Ackerman, S | 1 |
| Cattamanchi, A | 1 |
| Handley, MA | 1 |
| Li, XX | 1 |
| Xiao, SZ | 1 |
| Gu, FF | 1 |
| He, WP | 1 |
| Ni, YX | 1 |
| Han, LZ | 1 |
| Heffernan, JK | 1 |
| Valgepea, K | 1 |
| de Souza Pinto Lemgruber, R | 1 |
| Casini, I | 1 |
| Plan, M | 1 |
| Tappel, R | 1 |
| Simpson, SD | 1 |
| Köpke, M | 1 |
| Nielsen, LK | 1 |
| Marcellin, E | 1 |
| Cen, YK | 1 |
| Lin, JG | 1 |
| Wang, YL | 1 |
| Wang, JY | 1 |
| Liu, ZQ | 1 |
| Zheng, YG | 1 |
| Spirk, D | 1 |
| Noll, S | 1 |
| Burnier, M | 1 |
| Rimoldi, S | 1 |
| Noll, G | 1 |
| Sudano, I | 1 |
| Penzhorn, BL | 1 |
| Oosthuizen, MC | 1 |
| Kobos, LM | 1 |
| Alqatani, S | 1 |
| Ferreira, CR | 1 |
| Aryal, UK | 1 |
| Hedrick, V | 1 |
| Sobreira, TJP | 1 |
| Shannahan, JH | 1 |
| Gale, P | 1 |
| Singhroy, DN | 1 |
| MacLean, E | 1 |
| Kohli, M | 1 |
| Lessem, E | 1 |
| Branigan, D | 1 |
| England, K | 1 |
| Suleiman, K | 1 |
| Drain, PK | 1 |
| Ruhwald, M | 1 |
| Schumacher, S | 1 |
| Denkinger, CM | 1 |
| Waning, B | 1 |
| Van Gemert, W | 1 |
| Pai, M | 1 |
| Myers, RK | 1 |
| Bonsu, JM | 1 |
| Carey, ME | 1 |
| Yerys, BE | 1 |
| Mollen, CJ | 1 |
| Curry, AE | 1 |
| Douglas, TA | 1 |
| Alinezhadbalalami, N | 1 |
| Balani, N | 1 |
| Schmelz, EM | 1 |
| Davalos, RV | 1 |
| Kamaldinov, T | 1 |
| Erndt-Marino, J | 1 |
| Levin, M | 1 |
| Kaplan, DL | 1 |
| Hahn, MS | 1 |
| Heidarimoghadam, R | 1 |
| Farmany, A | 1 |
| Lee, JJ | 1 |
| Kang, J | 1 |
| Park, S | 1 |
| Cho, JH | 1 |
| Oh, S | 1 |
| Park, DJ | 1 |
| Perez-Maldonado, R | 1 |
| Cho, JY | 1 |
| Park, IH | 1 |
| Kim, HB | 1 |
| Song, M | 1 |
| Mfarrej, B | 1 |
| Jofra, T | 1 |
| Morsiani, C | 1 |
| Gagliani, N | 1 |
| Fousteri, G | 1 |
| Battaglia, M | 1 |
| Giuliano, C | 1 |
| Levinger, I | 1 |
| Vogrin, S | 1 |
| Neil, CJ | 1 |
| Allen, JD | 1 |
| Lv, Y | 1 |
| Yuan, R | 1 |
| Cai, B | 1 |
| Bahrami, B | 1 |
| Chowdhury, AH | 1 |
| Yang, C | 2 |
| Qiao, Q | 1 |
| Liu, SF | 1 |
| Zhang, WH | 1 |
| Kolano, L | 1 |
| Knappe, D | 1 |
| Volke, D | 1 |
| Sträter, N | 1 |
| Hoffmann, R | 1 |
| Coussens, M | 1 |
| Calders, P | 1 |
| Lapauw, B | 1 |
| Celie, B | 1 |
| Banica, T | 1 |
| De Wandele, I | 1 |
| Pacey, V | 1 |
| Malfait, F | 1 |
| Rombaut, L | 1 |
| Vieira, D | 1 |
| Angel, S | 1 |
| Honjol, Y | 1 |
| Gruenheid, S | 1 |
| Gbureck, U | 1 |
| Harvey, E | 1 |
| Merle, G | 1 |
| Seo, G | 1 |
| Lee, G | 1 |
| Kim, MJ | 1 |
| Baek, SH | 1 |
| Choi, M | 1 |
| Ku, KB | 1 |
| Lee, CS | 1 |
| Jun, S | 1 |
| Park, D | 1 |
| Kim, HG | 1 |
| Kim, SJ | 1 |
| Lee, JO | 1 |
| Kim, BT | 1 |
| Park, EC | 1 |
| Kim, SI | 1 |
| Ende, M | 1 |
| Kirkkala, T | 1 |
| Loitzenbauer, M | 1 |
| Talla, D | 1 |
| Wildner, M | 1 |
| Miletich, R | 1 |
| Criado, A | 1 |
| Lavela, P | 1 |
| Tirado, JL | 1 |
| Pérez-Vicente, C | 1 |
| Kang, D | 1 |
| Feng, D | 2 |
| Fang, Z | 1 |
| Wei, F | 1 |
| De Clercq, E | 1 |
| Pannecouque, C | 1 |
| Zhan, P | 1 |
| Guo, Y | 1 |
| Shen, Y | 1 |
| Wang, Q | 2 |
| Kawazoe, Y | 1 |
| Jena, P | 1 |
| Sun, Z | 1 |
| Li, Z | 2 |
| Liang, H | 1 |
| Xu, X | 1 |
| Ma, G | 1 |
| Huo, X | 1 |
| Church, JS | 1 |
| Chace-Donahue, F | 1 |
| Blum, JL | 1 |
| Ratner, JR | 1 |
| Zelikoff, JT | 1 |
| Schwartzer, JJ | 1 |
| Fiseha, T | 1 |
| Tamir, Z | 1 |
| Yao, W | 1 |
| Wang, P | 1 |
| Mi, K | 1 |
| Cheng, J | 1 |
| Gu, C | 1 |
| Huang, J | 2 |
| Sun, HB | 1 |
| Xing, WQ | 1 |
| Liu, XB | 1 |
| Zheng, Y | 1 |
| Yang, SJ | 1 |
| Wang, ZF | 1 |
| Liu, SL | 1 |
| Ba, YF | 1 |
| Zhang, RX | 1 |
| Liu, BX | 1 |
| Fan, CC | 1 |
| Chen, PN | 1 |
| Liang, GH | 1 |
| Yu, YK | 1 |
| Wang, HR | 1 |
| Li, HM | 1 |
| Li, ZX | 1 |
| Lalani, SS | 1 |
| Anasir, MI | 1 |
| Poh, CL | 1 |
| Khan, IT | 1 |
| Nadeem, M | 1 |
| Imran, M | 1 |
| Khalique, A | 1 |
| Raspini, B | 1 |
| Porri, D | 1 |
| De Giuseppe, R | 1 |
| Chieppa, M | 1 |
| Liso, M | 1 |
| Cerbo, RM | 1 |
| Civardi, E | 1 |
| Garofoli, F | 1 |
| Monti, MC | 1 |
| Vacca, M | 1 |
| De Angelis, M | 1 |
| Cena, H | 1 |
| Kong, D | 1 |
| Han, X | 1 |
| Zhou, Y | 4 |
| Xue, H | 1 |
| Zhang, W | 1 |
| Ruan, Z | 1 |
| Li, S | 3 |
| Noer, PR | 1 |
| Kjaer-Sorensen, K | 1 |
| Juhl, AK | 1 |
| Goldstein, A | 1 |
| Ke, C | 1 |
| Oxvig, C | 1 |
| Duan, C | 1 |
| Kong, F | 1 |
| Lin, S | 1 |
| Wang, Z | 3 |
| Bhattacharya, R | 1 |
| Mazumder, D | 1 |
| Yan, X | 1 |
| Ma, C | 1 |
| Tang, Y | 1 |
| Kong, X | 1 |
| Lu, J | 1 |
| Zhang, M | 1 |
| Vital-Jacome, M | 1 |
| Cazares-Granillo, M | 1 |
| Carrillo-Reyes, J | 1 |
| Buitron, G | 1 |
| Jacob, SI | 1 |
| Douair, I | 1 |
| Maron, L | 1 |
| Ménard, G | 1 |
| Rusjan, P | 1 |
| Sabioni, P | 1 |
| Di Ciano, P | 1 |
| Mansouri, E | 1 |
| Boileau, I | 1 |
| Laveillé, A | 1 |
| Capet, M | 1 |
| Duvauchelle, T | 1 |
| Schwartz, JC | 1 |
| Robert, P | 1 |
| Le Foll, B | 1 |
| Xia, Y | 1 |
| Chen, S | 1 |
| Luo, M | 1 |
| Wu, J | 1 |
| Cai, S | 1 |
| He, Y | 2 |
| Garbacz, P | 1 |
| Misiak, M | 1 |
| Jackowski, K | 1 |
| Yuan, Q | 1 |
| Sherrell, PC | 1 |
| Chen, J | 2 |
| Bi, X | 1 |
| Nutho, B | 1 |
| Mahalapbutr, P | 1 |
| Hengphasatporn, K | 1 |
| Pattaranggoon, NC | 1 |
| Simanon, N | 1 |
| Shigeta, Y | 1 |
| Hannongbua, S | 1 |
| Rungrotmongkol, T | 1 |
| Caffrey, PJ | 1 |
| Kher, R | 1 |
| Bian, K | 1 |
| Delaney, S | 1 |
| Xue, J | 1 |
| Wu, P | 1 |
| Xu, L | 1 |
| Yuan, Y | 2 |
| Ye, S | 1 |
| Ustriyana, P | 1 |
| Wei, B | 1 |
| Raee, E | 1 |
| Hu, Y | 1 |
| Wesdemiotis, C | 1 |
| Sahai, N | 1 |
| Kaur, A | 1 |
| Nigam, K | 1 |
| Srivastava, S | 1 |
| Tyagi, A | 1 |
| Dang, S | 1 |
| Millar, JE | 1 |
| Bartnikowski, N | 1 |
| Passmore, MR | 1 |
| Obonyo, NG | 1 |
| Malfertheiner, MV | 1 |
| von Bahr, V | 1 |
| Redd, MA | 1 |
| See Hoe, L | 1 |
| Ki, KK | 1 |
| Pedersen, S | 1 |
| Boyle, AJ | 1 |
| Baillie, JK | 1 |
| Shekar, K | 1 |
| Palpant, N | 1 |
| Suen, JY | 1 |
| Matthay, MA | 1 |
| McAuley, DF | 1 |
| Fraser, JF | 1 |
| Settles, JA | 1 |
| Gerety, GF | 1 |
| Spaepen, E | 1 |
| Suico, JG | 1 |
| Child, CJ | 1 |
| Oh, BL | 1 |
| Lee, JS | 1 |
| Lee, EY | 1 |
| Lee, HY | 1 |
| Yu, HG | 1 |
| Leslie, I | 1 |
| Boos, LA | 1 |
| Larkin, J | 1 |
| Pickering, L | 1 |
| Lima, HK | 1 |
| Vogel, K | 1 |
| Hampel, D | 1 |
| Wagner-Gillespie, M | 1 |
| Fogleman, AD | 1 |
| Ferraz, SL | 1 |
| O'Connor, M | 1 |
| Mazzucchelli, TG | 1 |
| Kajiyama, H | 1 |
| Suzuki, S | 1 |
| Shimbo, A | 1 |
| Utsumi, F | 1 |
| Yoshikawa, N | 1 |
| Kikkawa, F | 1 |
| Javvaji, PK | 1 |
| Dhali, A | 1 |
| Francis, JR | 1 |
| Kolte, AP | 1 |
| Roy, SC | 1 |
| Selvaraju, S | 1 |
| Mech, A | 1 |
| Sejian, V | 1 |
| DeSilva, S | 1 |
| Vaidya, SS | 1 |
| Mao, C | 1 |
| Akhatayeva, Z | 1 |
| Cheng, H | 1 |
| Zhang, G | 1 |
| Jiang, F | 1 |
| Meng, X | 1 |
| Elnour, IE | 1 |
| Lan, X | 1 |
| Song, E | 1 |
| Rohde, S | 1 |
| Antonides, CFJ | 1 |
| Muslem, R | 1 |
| de Woestijne, PCV | 1 |
| der Meulen, MHV | 1 |
| Kraemer, US | 1 |
| Dalinghaus, M | 1 |
| Bogers, AJJC | 1 |
| Pourmand, A | 1 |
| Ghassemi, M | 1 |
| Sumon, K | 1 |
| Amini, SB | 1 |
| Hood, C | 1 |
| Sikka, N | 1 |
| Duan, H | 1 |
| Chen, WP | 1 |
| Fan, M | 1 |
| Wang, WP | 1 |
| Yu, L | 1 |
| Tan, SJ | 1 |
| Xin, S | 1 |
| Wan, LJ | 1 |
| Guo, YG | 1 |
| Tanda, S | 1 |
| Gingl, K | 1 |
| Ličbinský, R | 1 |
| Hegrová, J | 1 |
| Goessler, W | 1 |
| Li, ZL | 1 |
| Zhou, YL | 1 |
| Yan, W | 1 |
| Luo, L | 1 |
| Su, ZZ | 1 |
| Fan, MZ | 1 |
| Wang, SR | 1 |
| Zhao, WG | 1 |
| Xu, D | 1 |
| Hassan, HM | 1 |
| Jiang, Z | 1 |
| Bachmann, KF | 1 |
| Haenggi, M | 1 |
| Jakob, SM | 1 |
| Takala, J | 1 |
| Gattinoni, L | 1 |
| Berger, D | 1 |
| Bentley, RF | 1 |
| Vecchiarelli, E | 1 |
| Banks, L | 1 |
| Gonçalves, PEO | 1 |
| Thomas, SG | 1 |
| Goodman, JM | 1 |
| Mather, K | 1 |
| Boachie, R | 1 |
| Anini, Y | 1 |
| Panahi, S | 1 |
| Anderson, GH | 1 |
| Luhovyy, BL | 1 |
| Nafie, MS | 1 |
| Arafa, K | 1 |
| Sedky, NK | 1 |
| Alakhdar, AA | 1 |
| Arafa, RK | 1 |
| Fan, S | 1 |
| Hu, H | 1 |
| Liang, J | 1 |
| Hu, BC | 1 |
| Wen, Z | 1 |
| Hu, D | 1 |
| Liu, YY | 1 |
| Chu, Q | 1 |
| Wu, MC | 1 |
| Lu, X | 1 |
| Wang, D | 2 |
| Hu, M | 1 |
| Shen, H | 1 |
| Yao, M | 1 |
| Dahlgren, RA | 1 |
| Vysloužil, J | 1 |
| Kulich, P | 1 |
| Zeman, T | 1 |
| Vaculovič, T | 1 |
| Tvrdoňová, M | 1 |
| Mikuška, P | 1 |
| Večeřa, Z | 1 |
| Stráská, J | 1 |
| Moravec, P | 1 |
| Balcar, VJ | 1 |
| Šerý, O | 1 |
| Qiao, L | 1 |
| Xiong, X | 1 |
| Peng, X | 1 |
| Zheng, J | 1 |
| Duan, J | 1 |
| Xiao, W | 1 |
| Zhou, HY | 1 |
| Sui, ZY | 1 |
| Zhao, FL | 1 |
| Sun, YN | 1 |
| Wang, HY | 1 |
| Han, BH | 1 |
| Jintao, X | 1 |
| Shasha, Y | 1 |
| Jincai, W | 1 |
| Chunyan, L | 1 |
| Mengya, Y | 1 |
| Yongli, S | 1 |
| Rasoanirina, BNV | 1 |
| Lassoued, MA | 1 |
| Miladi, K | 1 |
| Razafindrakoto, Z | 1 |
| Chaâbane-Banaoues, R | 1 |
| Ramanitrahasimbola, D | 1 |
| Cornet, M | 1 |
| Sfar, S | 1 |
| Liang, C | 1 |
| Xing, Q | 1 |
| Yi, JL | 1 |
| Zhang, YQ | 1 |
| Li, CY | 1 |
| Tang, SJ | 1 |
| Gao, C | 1 |
| Sun, X | 1 |
| Peng, M | 1 |
| Sun, XF | 1 |
| Zhang, T | 1 |
| Shi, JH | 1 |
| Liao, CX | 1 |
| Gao, WJ | 1 |
| Sun, LL | 1 |
| Gao, Y | 1 |
| Cao, WH | 1 |
| Lyu, J | 1 |
| Yu, CQ | 1 |
| Wang, SF | 1 |
| Pang, ZC | 1 |
| Cong, LM | 1 |
| Dong, Z | 1 |
| Wu, F | 1 |
| Wu, XP | 1 |
| Jiang, GH | 1 |
| Wang, XJ | 1 |
| Wang, BY | 1 |
| Li, LM | 1 |
| Pan, L | 1 |
| Wan, SP | 1 |
| Yi, HWL | 1 |
| He, HJ | 1 |
| Yong, ZP | 1 |
| Shan, GL | 1 |
| Weng, TT | 1 |
| Yan, SQ | 1 |
| Gao, GP | 1 |
| Wei, C | 1 |
| Tao, FB | 1 |
| Shao, ZH | 1 |
| Yao, T | 1 |
| Dong, S | 1 |
| Shi, S | 1 |
| Feng, YL | 1 |
| Zhang, YW | 1 |
| Wang, SP | 1 |
| Shi, AX | 1 |
| Operario, D | 1 |
| Zhang, ZH | 1 |
| Zhu, XF | 1 |
| Zaller, N | 1 |
| Gao, P | 1 |
| Sun, YH | 1 |
| Zhang, HB | 1 |
| Su, H | 1 |
| Li, R | 2 |
| Zhong, N | 1 |
| Green, TC | 1 |
| Bratberg, J | 1 |
| Finnell, DS | 1 |
| Pena, E | 1 |
| Ahmed, S | 1 |
| Schimmel, J | 1 |
| Manini, AF | 1 |
| Fingerhood, MI | 1 |
| Agus, D | 1 |
| Cochran, G | 1 |
| Bruneau, J | 1 |
| Cox, N | 1 |
| Gordon, AJ | 1 |
| Andrade, G | 1 |
| Simões do Couto, F | 1 |
| Câmara-Pestana, L | 1 |
| Ortiz-Barrios, M | 1 |
| Gul, M | 1 |
| López-Meza, P | 1 |
| Yucesan, M | 1 |
| Navarro-Jiménez, E | 1 |
| Khuntia, HK | 1 |
| Chanakya, HN | 1 |
| D'Arienzo, M | 1 |
| Coniglio, A | 1 |
| Boag, AM | 1 |
| Short, A | 1 |
| Kennedy, LJ | 1 |
| Syme, H | 1 |
| Graham, PA | 1 |
| Catchpole, B | 1 |
| Tofighi, B | 1 |
| El Shahawy, O | 1 |
| Segoshi, A | 1 |
| Moreno, KP | 1 |
| Badiei, B | 1 |
| Sarker, A | 1 |
| Guo, B | 1 |
| Xia, S | 1 |
| Nielsen, CU | 1 |
| Pedersen, M | 1 |
| Müller, S | 1 |
| Kæstel, T | 1 |
| Bjerg, M | 1 |
| Ulaganathan, N | 1 |
| Nielsen, S | 1 |
| Carlsen, KL | 1 |
| Nøhr, MK | 1 |
| Holm, R | 1 |
| Dottino, JA | 1 |
| Loose, DS | 1 |
| Fellman, B | 1 |
| Melendez, BD | 1 |
| Borthwick, MS | 1 |
| McKenzie, LJ | 1 |
| Yang, RK | 1 |
| Broaddus, RR | 1 |
| Lu, KH | 1 |
| Soliman, PT | 1 |
| Yates, MS | 1 |
| Hasegawa, K | 1 |
| Ma, B | 1 |
| Fujiogi, M | 1 |
| Camargo, CA | 1 |
| Liang, L | 1 |
| Sangroula, S | 1 |
| Baez Vasquez, AY | 1 |
| Raut, P | 1 |
| Obeng, B | 1 |
| Shim, JK | 1 |
| Bagley, GD | 1 |
| West, BE | 1 |
| Burnell, JE | 1 |
| Kinney, MS | 1 |
| Potts, CM | 1 |
| Weller, SR | 1 |
| Kelley, JB | 1 |
| Hess, ST | 1 |
| Gosse, JA | 1 |
| Breves, JP | 1 |
| Springer-Miller, RH | 1 |
| Chenoweth, DA | 1 |
| Paskavitz, AL | 1 |
| Chang, AYH | 1 |
| Regish, AM | 1 |
| Einarsdottir, IE | 1 |
| Björnsson, BT | 1 |
| McCormick, SD | 1 |
| Villmones, HC | 1 |
| Halland, A | 1 |
| Stenstad, T | 1 |
| Ulvestad, E | 1 |
| Weedon-Fekjær, H | 1 |
| Kommedal, Ø | 1 |
| Nasri, A | 1 |
| Jaleh, B | 1 |
| Khazalpour, S | 1 |
| Nasrollahzadeh, M | 1 |
| Shokouhimehr, M | 1 |
| Ferrario, M | 1 |
| Fenoglio, D | 1 |
| Chantada, A | 1 |
| Guerrero, S | 1 |
| Odetayo, AA | 1 |
| Reible, DD | 1 |
| Acevedo-Mackey, D | 1 |
| Price, C | 1 |
| Thai, L | 1 |
| Lin, Y | 1 |
| Chen, Y | 2 |
| Nie, E | 1 |
| Gao, X | 1 |
| Akhtar, K | 1 |
| Ye, Q | 1 |
| Wang, M | 2 |
| Dai, Y | 2 |
| Guo, X | 1 |
| An, Y | 1 |
| Chai, C | 1 |
| Sang, J | 1 |
| Jiang, L | 1 |
| Lu, F | 1 |
| Liu, F | 1 |
| Pu, Y | 1 |
| Zhou, B | 1 |
| Xiang, H | 1 |
| Yin, H | 1 |
| Yue, W | 1 |
| Shaw, L | 1 |
| Shaw, D | 1 |
| Hardisty, M | 1 |
| Britz-McKibbin, P | 1 |
| Verma, DK | 1 |
| Wufuer, R | 1 |
| Duo, J | 1 |
| Wang, S | 1 |
| Luo, Y | 1 |
| Zhang, D | 1 |
| Pan, X | 1 |
| Jones, DL | 1 |
| Baluja, MQ | 1 |
| Graham, DW | 1 |
| Corbishley, A | 1 |
| McDonald, JE | 1 |
| Malham, SK | 1 |
| Hillary, LS | 1 |
| Connor, TR | 1 |
| Gaze, WH | 1 |
| Moura, IB | 1 |
| Wilcox, MH | 1 |
| Farkas, K | 1 |
| Shao, X | 1 |
| Ji, X | 1 |
| Tian, G | 1 |
| Sun, R | 1 |
| Tuyiringire, D | 1 |
| Li, K | 1 |
| Han, W | 1 |
| Yan, L | 1 |
| El Hayany, B | 1 |
| El Fels, L | 1 |
| Quénéa, K | 1 |
| Dignac, MF | 1 |
| Rumpel, C | 1 |
| Gupta, VK | 1 |
| Hafidi, M | 1 |
| de Oliveira, BR | 1 |
| Bragança, MLBM | 1 |
| Batalha, MA | 1 |
| Coelho, CCNDS | 1 |
| Bettiol, H | 1 |
| Barbieri, MA | 1 |
| Saraiva, MDCP | 1 |
| Kac, G | 1 |
| da Silva, AAM | 1 |
| Rather, BA | 1 |
| Mir, IR | 1 |
| Sehar, Z | 1 |
| Anjum, NA | 1 |
| Masood, A | 1 |
| Khan, NA | 1 |
| Songsamoe, S | 1 |
| Koomhin, P | 1 |
| Matan, N | 1 |
| Flögel, F | 1 |
| Gärtner, S | 1 |
| Rahimi Khonakdari, M | 1 |
| Rezadoost, H | 1 |
| Heydari, R | 1 |
| Mirjalili, MH | 1 |
| Kebaili, I | 1 |
| Boukhris, I | 1 |
| Sayyed, MI | 1 |
| Tonguc, B | 1 |
| Al-Buriahi, MS | 1 |
| Ganson, KT | 1 |
| Nagata, JM | 1 |
| Cole, MA | 2 |
| Ozgen, C | 1 |
| Strobl, E | 1 |
| Coker, ES | 1 |
| Cavalli, L | 1 |
| Fabrizi, E | 1 |
| Guastella, G | 1 |
| Lippo, E | 1 |
| Parisi, ML | 1 |
| Pontarollo, N | 1 |
| Rizzati, M | 1 |
| Varacca, A | 1 |
| Vergalli, S | 1 |
| Elliott, RJR | 1 |
| Liu, B | 1 |
| Bajelan, S | 1 |
| Bahreini, MS | 1 |
| Asgari, Q | 1 |
| Mikaeili, F | 1 |
| Lakmal, MAC | 1 |
| Ekanayake, EMDNK | 1 |
| Kelum, SHP | 1 |
| Gamage, BD | 1 |
| Jayasundara, JASB | 1 |
| Gautam, S | 1 |
| Gautam, A | 1 |
| Chhetri, S | 1 |
| Bhattarai, U | 1 |
| Acharjee, N | 1 |
| Patel, AK | 1 |
| Lodha, D | 1 |
| Shekhawat, NS | 1 |
| Zeng, W | 1 |
| Dong, A | 1 |
| Cheng, ZL | 1 |
| Campo, M | 1 |
| Amandi, A | 1 |
| Biset, JC | 1 |
| Roviello, V | 1 |
| Roviello, GN | 1 |
| Gandhi, D | 1 |
| Weintraub, E | 1 |
| Trujols, J | 1 |
| Larrabeiti, A | 1 |
| Sànchez, O | 1 |
| Madrid, M | 1 |
| De Andrés, S | 1 |
| Duran-Sindreu, S | 1 |
| Del Pozo, B | 1 |
| Rich, JD | 1 |
| O'Carroll, A | 1 |
| Duffin, T | 1 |
| Collins, J | 1 |
| Meteliuk, A | 1 |
| Galvez de Leon, SJ | 1 |
| Madden, LM | 1 |
| Pykalo, I | 1 |
| Fomenko, T | 1 |
| Filippovych, M | 1 |
| Farnum, SO | 1 |
| Dvoryak, S | 1 |
| Islam, ZM | 1 |
| Altice, FL | 1 |
| Nunes, EV | 1 |
| Levin, FR | 1 |
| Reilly, MP | 1 |
| El-Bassel, N | 1 |
| Donelan, CJ | 1 |
| Hayes, E | 1 |
| Schwartz, L | 1 |
| Evans, EA | 1 |
| Hughto, JMW | 1 |
| Peterson, L | 1 |
| Perry, NS | 1 |
| Donoyan, A | 1 |
| Mimiaga, MJ | 1 |
| Nelson, KM | 1 |
| Pantalone, DW | 1 |
| Ameral, V | 1 |
| Weisberg, RB | 1 |
| Hatch-Maillette, MA | 1 |
| Peavy, KM | 1 |
| Banta-Green, CJ | 1 |
| Joseph, G | 1 |
| Torres-Lockhart, K | 1 |
| Stein, MR | 1 |
| Mund, PA | 1 |
| Nahvi, S | 1 |
| Dunn, KE | 2 |
| Brooner, RK | 2 |
| Frank, D | 1 |
| Stringer, KL | 1 |
| Langdon, KJ | 1 |
| McKenzie, M | 1 |
| Brockmann, B | 1 |
| Marotta, P | 1 |
| Figgatt, MC | 1 |
| Salazar, Z | 1 |
| Day, E | 1 |
| Dasgupta, N | 1 |
| Jacka, BP | 1 |
| Janssen, T | 1 |
| Garner, BR | 1 |
| Yermash, J | 1 |
| Yap, KR | 1 |
| Ball, EL | 1 |
| Hartzler, B | 1 |
| Becker, SJ | 1 |
| Mehtani, NJ | 1 |
| Ristau, JT | 1 |
| Snyder, H | 1 |
| Surlyn, C | 1 |
| Eveland, J | 1 |
| Smith-Bernardin, S | 1 |
| Bachireddy, C | 1 |
| Terplan, M | 1 |
| Clark, SA | 1 |
| Davis, C | 1 |
| Wightman, RS | 1 |
| Wunsch, C | 1 |
| Keeler, LAJ | 1 |
| Reddy, N | 1 |
| Samuels, EA | 1 |
| Hunter, SB | 1 |
| Dopp, AR | 1 |
| Ober, AJ | 1 |
| Uscher-Pines, L | 1 |
| Guille, C | 1 |
| McCauley, JL | 1 |
| Moreland, A | 1 |
| Arya, S | 1 |
| Aggarwal, N | 1 |
| Kumar, V | 1 |
| Rathee, S | 1 |
| Rani, M | 1 |
| Madaan, N | 1 |
| Malik, G | 1 |
| Gupta, R | 1 |
| Viera, A | 1 |
| Heimer, R | 1 |
| Kidorf, M | 1 |
| Peirce, JM | 1 |
| Smit, AM | 1 |
| Kilian, S | 1 |
| Emsley, RA | 1 |
| Luckhoff, HK | 1 |
| Swartz, L | 1 |
| Seedat, S | 1 |
| Asmal, L | 1 |
| Kloppers, JF | 1 |
| de Kock, A | 1 |
| Cronjé, J | 1 |
| van Marle, AC | 1 |
| Aouad, MR | 1 |
| Khan, DJO | 1 |
| Said, MA | 1 |
| Al-Kaff, NS | 1 |
| Rezki, N | 1 |
| Ali, AA | 1 |
| Bouqellah, N | 1 |
| Hagar, M | 1 |
| Sanga, G | 1 |
| Jao, I | 1 |
| Mumba, N | 1 |
| Mwalukore, S | 1 |
| Kamuya, D | 1 |
| Davies, A | 1 |
| McGready, R | 1 |
| Rijken, MJ | 1 |
| Turner, C | 1 |
| Than, HH | 1 |
| Tun, NW | 1 |
| Min, AM | 1 |
| Hla, S | 1 |
| Wai, NS | 1 |
| Proux, K | 1 |
| Min, TH | 1 |
| Gilder, ME | 1 |
| Sneddon, A | 1 |
| Sorbera, M | 1 |
| Fischetti, B | 1 |
| Khaimova, R | 1 |
| Niewinski, M | 1 |
| Wen, K | 1 |
| Tarke, A | 1 |
| Sidney, J | 1 |
| Methot, N | 1 |
| Yu, ED | 1 |
| Dan, JM | 1 |
| Goodwin, B | 1 |
| Rubiro, P | 1 |
| Sutherland, A | 1 |
| Wang, E | 1 |
| Frazier, A | 1 |
| Ramirez, SI | 1 |
| Rawlings, SA | 1 |
| Smith, DM | 1 |
| da Silva Antunes, R | 1 |
| Peters, B | 1 |
| Scheuermann, RH | 1 |
| Weiskopf, D | 1 |
| Crotty, S | 1 |
| Grifoni, A | 1 |
| Sette, A | 1 |
| Yan, P | 1 |
| Liang, DY | 1 |
| Xu, WH | 1 |
| Xue, L | 1 |
| Yu, MF | 1 |
| Shen, JH | 1 |
| Liu, QH | 1 |
| Peng, YB | 1 |
| Arenas, M | 1 |
| Algara, M | 1 |
| De Febrer, G | 1 |
| Rubio, C | 1 |
| Sanz, X | 1 |
| de la Casa, MA | 1 |
| Vasco, C | 1 |
| Marín, J | 1 |
| Fernández-Letón, P | 1 |
| Villar, J | 1 |
| Torres-Royo, L | 1 |
| Villares, P | 1 |
| Membrive, I | 1 |
| Acosta, J | 1 |
| López-Cano, M | 1 |
| Araguas, P | 1 |
| Quera, J | 1 |
| Rodríguez-Tomás, F | 1 |
| Montero, A | 1 |
| Buchler, A | 1 |
| Munch, M | 1 |
| Farber, G | 1 |
| Al-Haddad, R | 1 |
| Farber, E | 1 |
| Rotstein, BH | 1 |
| Hou, J | 1 |
| Long, T | 1 |
| Yang, N | 1 |
| Zeng, S | 1 |
| Zheng, K | 1 |
| Liao, G | 1 |
| Hu, S | 1 |
| De Gregori, S | 1 |
| De Silvestri, A | 1 |
| Molinaro, MD | 1 |
| Monzillo, V | 1 |
| Biscarini, S | 1 |
| Colaneri, M | 1 |
| Gallazzi, I | 1 |
| Bartoli, A | 1 |
| Bruno, R | 1 |
| Seminari, E | 1 |
| Dang, W | 1 |
| Xiao, J | 1 |
| Miao, J | 1 |
| Cao, M | 1 |
| Shi, Y | 1 |
| Yao, X | 1 |
| Yu, S | 1 |
| Bian, X | 1 |
| Norlin, JM | 1 |
| Kellerborg, K | 1 |
| Odin, P | 1 |
| Van Buren, S | 1 |
| Chaiton, JA | 1 |
| Ehrenfeld, L | 1 |
| Guerra, ME | 1 |
| Gleeson, B | 1 |
| Kimmel, SD | 1 |
| Medley, A | 1 |
| Mekideche, W | 1 |
| Paquet, M | 1 |
| Sung, M | 1 |
| You Kheang, ROO | 1 |
| Wang, EA | 1 |
| Edelman, EJ | 1 |
| Thorn, EL | 1 |
| Alexander, K | 1 |
| Pogorzelska-Maziarz, M | 1 |
| Gerolamo, A | 1 |
| Hassen, N | 1 |
| Kelly, EL | 1 |
| Rising, KL | 1 |
| Bart, G | 1 |
| Wastvedt, S | 1 |
| Hodges, JS | 1 |
| Rosenthal, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics[NCT04706624] | 640 participants (Anticipated) | Interventional | 2020-11-02 | Active, not recruiting | |||
| INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit to Link Persons Who Inject Drugs to Integrated Care and Prevention for Addiction, HIV, HCV and Primary Care[NCT04804072] | 450 participants (Anticipated) | Interventional | 2021-06-02 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for methadone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Review of medication-assisted treatment for opioid use disorder.
Topics: Buprenorphine; COVID-19; COVID-19 Drug Treatment; Humans; Methadone; Naltrexone; Opiate Substitution | 2022 |
Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?
Topics: Analgesics, Opioid; Canada; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Relat | 2022 |
Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy.
Topics: COVID-19; Humans; Methadone; Opioid-Related Disorders; Pandemics; Policy | 2023 |
Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review.
Topics: Australia; Canada; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disord | 2023 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
[Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].
Topics: Antiviral Agents; Benzodiazepines; Betacoronavirus; Bipolar Disorder; Body Temperature Regulation; B | 2020 |
Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Ai | 2020 |
Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Ai | 2020 |
Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Ai | 2020 |
Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Ai | 2020 |
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
Topics: Buprenorphine; COVID-19; Cross-Sectional Studies; Drug Overdose; Emergency Medical Services; Health | 2021 |
6 trials available for methadone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
An adaptive design to screen, treat, and retain people with opioid use disorders who use methamphetamine in methadone clinics (STAR-OM): study protocol of a clinical trial.
Topics: Adolescent; Amphetamine-Related Disorders; COVID-19; HIV Infections; Humans; Methadone; Methamphetam | 2022 |
Clinics Optimizing MEthadone Take-homes for opioid use disorder (COMET): Protocol for a stepped-wedge randomized trial to facilitate clinic level changes.
Topics: Analgesics, Opioid; COVID-19; Humans; Methadone; Opioid-Related Disorders; Randomized Controlled Tri | 2023 |
Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff.
Topics: Analgesics, Opioid; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disor | 2023 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P | 2016 |
Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic.
Topics: Adult; Analgesics, Opioid; COVID-19; Female; Humans; Male; Medication Adherence; Methadone; Opiate S | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies | 2021 |
87 other studies available for methadone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Treatment provider perceptions of take-home methadone regulation before and during COVID-19.
Topics: COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Per | 2021 |
COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.
Topics: Analgesics, Opioid; COVID-19; Humans; Leadership; Methadone; Opiate Substitution Treatment; Opioid-R | 2022 |
The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era.
Topics: COVID-19; Cross-Sectional Studies; Female; Humans; Male; Methadone; Pandemics; SARS-CoV-2; Treatment | 2021 |
Improving methadone access for rural communities in the USA: lessons learned from COVID-19 adaptations and international models of care.
Topics: COVID-19; Delivery of Health Care; Health Services Accessibility; Humans; Methadone; Opiate Substitu | 2021 |
"No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston.
Topics: Adolescent; Adult; Aged; Boston; COVID-19; Female; Humans; Male; Methadone; Middle Aged; Opiate Over | 2022 |
Implementing a Methadone Delivery System in New York City in Response to COVID-19.
Topics: Adult; Communicable Disease Control; Comorbidity; COVID-19; Female; Humans; Male; Methadone; Middle | 2021 |
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis.
Topics: Analgesics, Opioid; COVID-19; Humans; Methadone; Policy; Rural Population; SARS-CoV-2; United States | 2021 |
Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations.
Topics: Adolescent; Adult; Aged; COVID-19; Humans; Medicare; Methadone; Poison Control Centers; Retrospectiv | 2022 |
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients' and prescribers' experiences with changes in unsupervised dosing.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Humans; Methadone; Ontario; Opiate Substitution Treatme | 2022 |
Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
Topics: Adult; Analgesics, Opioid; Buprenorphine; COVID-19; Female; Humans; Male; Medication Adherence; Meth | 2022 |
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; COVID-19; Humans; Metha | 2022 |
Methadone as a rescue drug for difficult-to-sedate critically ill patients suffering from ARDS related to SARS-CoV-2 infection.
Topics: COVID-19; Critical Illness; Humans; Methadone; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
Surge of HIV, tuberculosis and COVID feared amid war in Ukraine.
Topics: Anti-HIV Agents; Armed Conflicts; COVID-19; HIV Infections; Humans; Immunization Programs; Male; Mea | 2022 |
Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19.
Topics: COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions.
Topics: Analgesics, Opioid; COVID-19; Drug Users; Humans; Methadone; Ontario; Opiate Substitution Treatment; | 2022 |
Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; COVID-19; Humans; Metha | 2022 |
"The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment.
Topics: Analgesics, Opioid; COVID-19; Drug Overdose; Female; Freedom; Humans; Male; Methadone; Middle Aged; | 2022 |
Kamini, a little recognised source of illicit opioid: A case series of 12 patients.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Humans; Methadone; Narcotic Antagonists; Opiate Substit | 2022 |
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis.
Topics: Analgesics, Opioid; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disor | 2022 |
Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; COVID-19; Drug Overdose; Female; | 2022 |
[Ensuring continuity of care at the time of COVID-19: challenges for the Dakar Integrated Support Center for Addictions].
Topics: Continuity of Patient Care; COVID-19; Humans; Methadone; Pandemics; Senegal | 2021 |
Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; | 2022 |
Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas.
Topics: Analgesics, Opioid; Arkansas; COVID-19; Drug Overdose; Fentanyl; Humans; Methadone; Methamphetamine; | 2022 |
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Topics: Aged; Analgesics, Opioid; Buprenorphine; COVID-19; Drug Overdose; Female; Humans; Longitudinal Studi | 2022 |
Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic.
Topics: Analgesics, Opioid; COVID-19; Feasibility Studies; Humans; Methadone; Opiate Substitution Treatment; | 2022 |
Managing acute opioid withdrawal with tramadol during COVID-19 lockdown in a peri-urban setting.
Topics: Adult; Analgesics, Opioid; Communicable Disease Control; COVID-19; Cross-Sectional Studies; Female; | 2022 |
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England.
Topics: Analgesics, Opioid; Buprenorphine; Communicable Disease Control; COVID-19; Humans; Methadone; Opiate | 2022 |
Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID.
Topics: Analgesics, Opioid; Arizona; Buprenorphine; COVID-19; COVID-19 Drug Treatment; Humans; Methadone; Op | 2022 |
The impact of the COVID-19 pandemic on harm reduction services in Catalonia: the experience of people who use drugs and harm reduction professionals.
Topics: Communicable Disease Control; COVID-19; Female; Harm Reduction; Humans; Male; Methadone; Pandemics; | 2022 |
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study.
Topics: Analgesics, Opioid; Buprenorphine; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Health Service | 2022 |
Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic.
Topics: Analgesics, Opioid; COVID-19; Disease Progression; Drug Overdose; Humans; Methadone; Opiate Overdose | 2023 |
Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic.
Topics: Analgesics, Opioid; COVID-19; Disease Progression; Drug Overdose; Humans; Methadone; Opiate Overdose | 2023 |
Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic.
Topics: Analgesics, Opioid; COVID-19; Disease Progression; Drug Overdose; Humans; Methadone; Opiate Overdose | 2023 |
Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic.
Topics: Analgesics, Opioid; COVID-19; Disease Progression; Drug Overdose; Humans; Methadone; Opiate Overdose | 2023 |
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy.
Topics: Analgesics, Opioid; Canada; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Methadone; Opia | 2022 |
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy.
Topics: Analgesics, Opioid; Canada; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Methadone; Opia | 2022 |
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy.
Topics: Analgesics, Opioid; Canada; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Methadone; Opia | 2022 |
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy.
Topics: Analgesics, Opioid; Canada; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Methadone; Opia | 2022 |
Examination of methadone involved overdoses during the COVID-19 pandemic.
Topics: Analgesics, Opioid; COVID-19; Drug Overdose; Humans; Methadone; Opiate Overdose; Opioid-Related Diso | 2023 |
Use of Methadone Versus Oxycodone to Facilitate Weaning of Parenteral Opioids in Critically Ill Adult Patients.
Topics: Adult; Analgesics, Opioid; COVID-19; Critical Illness; Humans; Methadone; Oxycodone; Prospective Stu | 2023 |
Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014-20.
Topics: Analgesics, Opioid; British Columbia; Buprenorphine; COVID-19; Eating; Health Expenditures; Humans; | 2023 |
Availability of timely methadone treatment in the United States and Canada during COVID-19: A census tract-level analysis.
Topics: Canada; COVID-19; Cross-Sectional Studies; Humans; Methadone; Pandemics; United States | 2023 |
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya.
Topics: Adult; Cohort Studies; COVID-19; Cross-Sectional Studies; Drug Users; Female; Harm Reduction; HIV In | 2023 |
Do the lockdown-imposed changes in a wastewater treatment plant catchment's socio-demographics impact longitudinal temporal trends in psychoactive pharmaceutical use?
Topics: Biomarkers; Citalopram; Communicable Disease Control; COVID-19; Demography; Desvenlafaxine Succinate | 2023 |
Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.
Topics: Analgesics, Opioid; Baltimore; COVID-19; Humans; Male; Methadone; Middle Aged; Opioid-Related Disord | 2023 |
Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey.
Topics: Analgesics, Opioid; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disor | 2023 |
Long-term wastewater-based surveillance and impacts of the COVID-19 pandemic on drug use trends in a U.S. Northeast rural town.
Topics: Amphetamine; Cocaine; COVID-19; Fentanyl; Humans; Hydrocodone; Methadone; N-Methyl-3,4-methylenediox | 2023 |
Patients' perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; COVID-19; Humans; Methadone; Opiate Substituti | 2023 |
"Sign Me Up": a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic.
Topics: Analgesics, Opioid; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Pandemics | 2023 |
Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.
Topics: Aged; Buprenorphine; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Medicare Part C; Metha | 2023 |
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis.
Topics: Analgesics, Opioid; British Columbia; Buprenorphine; Buprenorphine, Naloxone Drug Combination; COVID | 2023 |
Racial, Ethnic, and Sex Differences in Methadone-Involved Overdose Deaths Before and After the US Federal Policy Change Expanding Take-home Methadone Doses.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; COVID-19; Drug Overdose; Female; Humans; Ma | 2023 |
Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study.
Topics: Analgesics, Opioid; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disor | 2023 |
Individualizing methadone treatment with split dosing: An underutilized tool.
Topics: COVID-19; Humans; Methadone | 2023 |
Changes in Opioid Agonist Treatment Practice in Germany during the COVID-19 Pandemic: What Have Physicians Done, and What Would They Like to Keep Doing?
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Female; Humans; Male; Methadone; Middle Aged; Opiate Su | 2023 |
Increase in hospitalisation-associated methadone intoxication in France following first COVID-19 lockdown.
Topics: Adult; Communicable Disease Control; COVID-19; Drug Overdose; France; Hospitalization; Humans; Metha | 2023 |
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Cross-Sectional Studies; Female; General Practitioners; | 2023 |
COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central Pennsylvania.
Topics: Adult; Amphetamines; Analgesics, Opioid; Benzodiazepines; Cocaine; COVID-19; Humans; Methadone; Pand | 2023 |
Shift in hospital opioid use during the COVID-19 pandemic in Brazil: a time-series analysis of one million prescriptions.
Topics: Adult; Analgesics, Opioid; Brazil; COVID-19; Fentanyl; Humans; Methadone; Morphine; Opioid-Related D | 2023 |
Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown.
Topics: Analgesics, Opioid; Communicable Disease Control; COVID-19; Cross-Sectional Studies; Humans; Methado | 2023 |
Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic.
Topics: Analgesics, Opioid; COVID-19; Drug Overdose; Humans; Methadone; Opiate Substitution Treatment; Opioi | 2023 |
Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.
Topics: Ambulatory Care; Analgesics, Opioid; Anxiety; China; Coronavirus Infections; COVID-19; Delivery of H | 2020 |
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.
Topics: Betacoronavirus; Buprenorphine; Continuity of Patient Care; Coronavirus Infections; COVID-19; Humans | 2020 |
TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
Topics: Analgesics, Opioid; Betacoronavirus; Buprenorphine; Coronavirus Infections; COVID-19; Humans; Methad | 2020 |
Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes.
Topics: Adaptive Immunity; Analgesics, Opioid; Arrhythmias, Cardiac; Betacoronavirus; Coronavirus Infections | 2020 |
Lessons from COVID 19: Are we finally ready to make opioid treatment accessible?
Topics: Analgesics, Opioid; Buprenorphine; Coronavirus Infections; COVID-19; Humans; Methadone; Opiate Subst | 2020 |
Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
Topics: Analgesics, Opioid; Australia; Betacoronavirus; Buprenorphine; Canada; Community Pharmacy Services; | 2020 |
Overdue for an Overhaul: How Opioid Treatment Programs Can Learn From COVID-19.
Topics: Analgesics, Opioid; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Infection Control; Me | 2020 |
Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?
Topics: Ambulatory Care Facilities; Coronavirus Infections; COVID-19; Health Services Accessibility; Humans; | 2020 |
Revising our attitudes towards agonist medications and their diversion in a time of pandemic.
Topics: Analgesics, Opioid; Buprenorphine; Coronavirus Infections; COVID-19; Drug Overdose; Humans; Methadon | 2020 |
Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland.
Topics: Benzodiazepines; COVID-19; Harm Reduction; Health Policy; Housing; Humans; Ill-Housed Persons; Irela | 2021 |
Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Drug Overdose; Humans; Methadone; Opiate Substitution T | 2021 |
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
Topics: Black or African American; Buprenorphine; COVID-19; Health Services Accessibility; Healthcare Dispar | 2021 |
COVID-19 and treating incarcerated populations for opioid use disorder.
Topics: Buprenorphine; COVID-19; Humans; Massachusetts; Methadone; Naltrexone; Opiate Substitution Treatment | 2021 |
The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19.
Topics: Buprenorphine; Continuity of Patient Care; Counseling; COVID-19; Delivery of Health Care; Humans; Me | 2021 |
Unprecedented need and recommendations for harnessing data to guide future policy and practice for opioid use disorder treatment following COVID-19.
Topics: Big Data; Buprenorphine; COVID-19; Drug Overdose; Health Policy; Humans; Methadone; Narcotic Antagon | 2021 |
Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives.
Topics: Clinical Decision-Making; COVID-19; Health Personnel; Health Services Accessibility; Humans; Methado | 2021 |
Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19.
Topics: Appointments and Schedules; Buprenorphine; Clinical Decision-Making; COVID-19; Drug Overdose; Health | 2021 |
A chance to do it better: Methadone maintenance treatment in the age of Covid-19.
Topics: COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Quality Improv | 2021 |
Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder.
Topics: Buprenorphine; COVID-19; Health Services Needs and Demand; Humans; Methadone; Narcotic Antagonists; | 2021 |
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19.
Topics: Adolescent; Adult; COVID-19; Drug Dosage Calculations; Female; Humans; Male; Methadone; North Caroli | 2021 |
Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder.
Topics: Adult; Buprenorphine; Clinical Trials as Topic; COVID-19; Cross-Sectional Studies; Female; Harm Redu | 2021 |
COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
Topics: Adult; Alcoholism; Analgesics, Opioid; Buprenorphine; COVID-19; Delivery of Health Care; Feasibility | 2021 |
Payer strategies to ensure access to care for individuals with opioid use disorder during COVID-19.
Topics: Ambulatory Care; Buprenorphine; COVID-19; Health Services Accessibility; Humans; Insurance, Health, | 2021 |
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island.
Topics: Buprenorphine; COVID-19; Emergency Service, Hospital; Health Services Accessibility; Humans; Methado | 2021 |
Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study.
Topics: Adult; COVID-19; Female; Health Personnel; Health Services Accessibility; Humans; Interviews as Topi | 2021 |
Leveraging Telehealth in the United States to Increase Access to Opioid Use Disorder Treatment in Pregnancy and Postpartum During the COVID-19 Pandemic.
Topics: Adult; Buprenorphine; Comorbidity; Comprehensive Health Care; COVID-19; Delivery of Health Care; Evi | 2021 |
Challenges in methadone dispensing during Covid-19: An innovative approach using videocall based services.
Topics: COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; SARS-CoV-2 | 2021 |
Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.
Topics: Analgesics, Opioid; Connecticut; COVID-19; Drug Overdose; Humans; Methadone; Opiate Substitution Tre | 2021 |
Use of an electronic pillbox to increase number of methadone take-home doses during the COVID-19 pandemic.
Topics: COVID-19; Electronics; Female; Humans; Male; Methadone; Middle Aged; Pandemics; Patient Satisfaction | 2021 |
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada.
Topics: Ambulatory Care Facilities; Analgesics, Opioid; Canada; COVID-19; Cross-Sectional Studies; Financing | 2021 |
Changes in methadone take-home dosing before and after COVID-19.
Topics: Adult; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemi | 2022 |
Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year.
Topics: Analgesics, Opioid; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disor | 2022 |